Skip to content

Latest disclosed trades

Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.

See the trades

Updated Oct 29 · 1 feed behind: Insider filings, 3 days · Every feed →

All 18,993Congress 9,936Executive branch 203Insiders 8,854
AllBuysSells
Filed late
More filters
DemRepInd
HouseSenateExecutive
$15K+$50K+$100K+$250K+$1M+
Clear filters

Insiders · buys only · 8,854 trades

Trades
8,854
Buys 8,854 · Sells 0
People
2,363
Stocks
1,234
Disclosed value
$11.5B
range midpoints · Congress & executive
Filed late
1,178
  1. ▲ BUYOliver Engert Chief Administrative OfficerENOV Enovis CORP$23Kdisclosed Jun 11 · filed 1 day after the trade
  2. ▲ BUYRA Capital Nexus Fund III, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$4.3Mdisclosed Jun 11 · filed the same day
  3. ▲ BUYNicholas W Zillges President and CEOMBBC Marathon Bancorp, Inc.$7.8Kdisclosed Jun 11 · filed 2 days after the trade
  4. ▲ BUYAngeliki Frangou DirectorNMM Navios Maritime Partners L.P.$84.7Kdisclosed Jun 11 · filed the same day
  5. ▲ BUYCosta Jose Antonio Batista DirectorPICS PicS N.V.$199Kdisclosed Jun 10 · filed 2 days after the trade 1 rule fired
  6. ▲ BUYHorizon Kinetics Asset Management LLC 10% ownerRCG RENN Fund, Inc.$2.1Kdisclosed Jun 10 · filed 1 day after the trade
  7. ▲ BUYVivo Opportunity Cayman, LLC 10% ownerINM InMed Pharmaceuticals Inc.$5.3Kdisclosed Jun 10 · filed 20 days after the trade · late
  8. ▲ BUYVivo Opportunity Cayman Fund, L.P. 10% ownerINM InMed Pharmaceuticals Inc.$3.2Kdisclosed Jun 10 · filed 8 days after the trade · late
  9. ▲ BUYHaveli Investment Management LLC DirectorBLND Blend Labs, Inc.$304Kdisclosed Jun 10 · filed 1 day after the trade
  10. ▲ BUYVivo Opportunity Cayman Fund, L.P. 10% ownerINM InMed Pharmaceuticals Inc.$5.3Kdisclosed Jun 10 · filed 20 days after the trade · late
  11. ▲ BUYVivo Opportunity Cayman Fund, L.P. 10% ownerINM InMed Pharmaceuticals Inc.$11Kdisclosed Jun 10 · filed 7 days after the trade · late
  12. ▲ BUYVivo Opportunity Cayman Fund, L.P. 10% ownerINM InMed Pharmaceuticals Inc.$44.9Kdisclosed Jun 10 · filed 2 days after the trade
  13. ▲ BUYJoseph R Nerges 10% ownerCSPI Csp Inc$6.7Kdisclosed Jun 10 · filed 2 days after the trade
  14. ▲ BUYVivo Opportunity Fund Holdings, L.P. 10% ownerINM InMed Pharmaceuticals Inc.$23Kdisclosed Jun 10 · filed 9 days after the trade · late
  15. ▲ BUYHaveli Investments Software Fund I GP, LLC DirectorBLND Blend Labs, Inc.$1.2Mdisclosed Jun 10 · filed the same day
  16. ▲ BUYMichael E Pegram DirectorCZR Caesars Entertainment, Inc.$114Kdisclosed Jun 10 · filed 1,121 days after the trade · late
  17. ▲ BUYVivo Opportunity, LLC 10% ownerINM InMed Pharmaceuticals Inc.$7.9Kdisclosed Jun 10 · filed 5 days after the trade · late
  18. ▲ BUYThomas N Bohjalian DirectorSMRT SmartRent, Inc.$83.3Kdisclosed Jun 10 · filed the same day
  19. ▲ BUYVivo Opportunity Fund Holdings, L.P. 10% ownerINM InMed Pharmaceuticals Inc.$52.2Kdisclosed Jun 10 · filed 20 days after the trade · late
  20. ▲ BUYJack Jiajia Huang Chief Executive OfficerCOE 51Talk Online Education Group$1.2Mdisclosed Jun 10 · filed 9 days after the trade · late
  21. ▲ BUYWhanau Interests LLC DirectorBLND Blend Labs, Inc.$304Kdisclosed Jun 10 · filed 1 day after the trade
  22. ▲ BUYVivo Opportunity Cayman, LLC 10% ownerINM InMed Pharmaceuticals Inc.$2.6Kdisclosed Jun 10 · filed 12 days after the trade · late
  23. ▲ BUYHaveli Investments, L.P. DirectorBLND Blend Labs, Inc.$1.2Mdisclosed Jun 10 · filed the same day
  24. ▲ BUYVivo Opportunity Cayman, LLC 10% ownerINM InMed Pharmaceuticals Inc.$8Kdisclosed Jun 10 · filed 21 days after the trade · late
  25. ▲ BUYHaveli Brooks Aggregator, L.P. DirectorBLND Blend Labs, Inc.$304Kdisclosed Jun 10 · filed 1 day after the trade